Owlstone Medical

Breath biomarkers for lung cancer screening

United Kingdom
biomarkers diagnostics
asthma copd lung cancer
Visit Website

Owlstone Medical develops Breath Biopsy® technology for non-invasive diagnostics and biomarker discovery, focusing on diseases such as cancer, liver disease, respiratory, and cardiometabolic conditions. Their mission is to save lives and reduce healthcare costs by early disease detection through breath analysis.

Location

United Kingdom

Similar listings in category

Explore More

Eupnoos

Acoustic diagnostic biomarkers

AIDAR

Breath- and saliva-based biosensors

Arete Medtech

Combined spirometry, exhaled nitric oxide, and lung impedance / oscillometry